Seeing Is Believing
Currently out of the existing stock ratings of James Terwilliger, 15 are a BUY (75%), 5 are a HOLD (25%).
Analyst James Terwilliger, currently employed carries an average stock price target met ratio of 48% that have a potential upside of 29.55% achieved within 321 days.
James Terwilliger’s has documented 43 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on INFU, InfuSystems Holdings at 29-Dec-2021.
Analyst best performing recommendations are on ZYXI (ZYNEX).
The best stock recommendation documented was for ZYXI (ZYNEX) at 4/1/2020. The price target of $13.64 was fulfilled within 26 days with a profit of $3.81 (38.76%) receiving and performance score of 14.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$25
$5 (25.00%)
$48
2 years 3 days ago
(14-Dec-2022)
4/8 (50%)
$10.95 (77.94%)
512
Hold
$18
$-2 (-10.00%)
$32
2 years 6 months 9 days ago
(08-Jun-2022)
3/4 (75%)
$2.82 (18.58%)
194
Buy
$20
$20
2 years 7 months 12 days ago
(05-May-2022)
12/13 (92.31%)
$4.32 (27.55%)
430
Buy
$34
$14 (70.00%)
$34
2 years 8 months 18 days ago
(29-Mar-2022)
1/5 (20%)
$11.85 (53.50%)
295
Hold
$49
3 years 29 days ago
(18-Nov-2021)
9/11 (81.82%)
$15.66 (46.97%)
234
What Year was the first public recommendation made by James Terwilliger?